[Low-density lipoprotein cholesterol levels and lipid-lowering treatment status among young and middle-aged ultra-high-risk patients with acute coronary syndrome in China].

Liu, J; Zhao, D; Hao, Y C; Yang, N; Sun, Z Q; Liu, J

Liu, J; Zhao, D; Hao, Y C; Yang, N; Sun, Z Q; Liu, J.

Zhonghua Xin Xue Guan Bing Za Zhi ; 50(12): 1161-1168, 2022 Dec 24.

Article in Zh | MEDLINE | ID: mdl-36517436

Subject(s)

Acute Coronary Syndrome; Atherosclerosis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; United States; Humans; Male; Adult; Female; Cholesterol, LDL; Acute Coronary Syndrome/drug therapy; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; China; Atherosclerosis/drug therapy; Hypolipidemic Agents/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Atherosclerosis / Acute Coronary Syndrome Type of study: Etiology_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: America do norte / Asia Language: Zh Journal: Zhonghua Xin Xue Guan Bing Za Zhi Year: 2022 Document type: Article Country of publication: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google